Rosie Cooper – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Rosie Cooper on 2015-02-20.

To ask the Secretary of State for Health, pursuant to the Answer of 9 April 2014, Official Report, columns 261-3W, on psoriasis, what the conclusions were of the NICE Clinical Commissioning Group Outcomes Indicator Set Advisory Committee’s review of potential indicators for psoriasis derived from the NICE Psoriasis Quality Standard.

Norman Lamb

The National Institute for Health and Care Excellence (NICE) Clinical Commissioning Group Outcome Indicator Set (CCG OIS) Advisory Committee considered the following draft psoriasis indicators, derived from the NICE Psoriasis Quality Standard, at its meeting in October 2014:

– PSO 5.1 Psoriasis: assessment for psoriatic arthritis;

– PSO 6.2 Skin disease: time off school or work due to skin disease;

– PSO 6.3 Psoriasis: skin clearance; and

– PSO 3.2 Psoriasis: Patient experience: access to secondary care services.

It was the decision of the committee that the indicators did not meet the prioritisation criteria, as set out in the NICE Indicator Process guide. The primary reason for this was that the majority of care for people with psoriasis is provided in primary care and the CCG OIS is focused on care provided in secondary care. As such, the committee has not put forward any of the psoriasis indicators for further development and testing by the Health and Social Care Information Centre (HSCIC). The HSCIC has not, therefore, undertaken any further work on the development of Read Codes for this topic.

The NICE indicator process guide and the NICE consultation document setting out those indicators which did meet the prioritisation criteria can be found at the links below:

www.nice.org.uk/media/03E/31/Indicators_process_guide.pdf

www.nice.org.uk/media/default/Standards-and-indicators/CCGOIS-indicator-consultation.pdf

“